Log in to your Inderes Free account to see all free content on this page.

ExpreS2ion Biotech Holding

1.66 SEK

0.00%

Less than 1K followers

EXPRS2

First North Stockholm

Biotechnology & Pharmaceuticals

Health Care

Quarter data

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for ExpreS2ion Biotech Holding

Q4/242024Q1/25Q2/25Q3/25Q4/252025Q1/26
Revenue0.63.01.31.50.40.43.71.0
EBITDA-19.3-104.2-12.3-11.3-9.4-9.8-42.8-11.6
EBIT-19.7-67.7-12.7-11.7-9.7-10.2-44.3-11.9
EBIT-%-3,283.3 %-2,249.2 %-951.9 %-758.4 %-2,760.9 %-2,340.2 %-1,210.6 %-1,150.4 %
Profit before taxes-19.4-44.6-14.0-11.5-9.8-10.0-44.2-12.1
Net income-15.6-36.4-11.4-10.0-8.4-8.2-38.1-9.6
Login required

This content is only available for logged in users